Viking Therapeutics：为何成功的维持期数据未能挽救股价（VKTX）
· seekingalpha.com
Viking Therapeutics面临稀释风险、成本上升以及激烈的肥胖药物竞争。请阅读此处对VKTX股票的详细分析。
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions...